News Image

Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis

Provided By GlobeNewswire

Last update: Jul 16, 2025

-- Expanded funding builds on the initial agreement to accelerate development of Prime Editors for Cystic Fibrosis (CF) --

-- Prime Medicine to receive up to $24 million in additional funding from the Cystic Fibrosis Foundation --

Read more at globenewswire.com

PRIME MEDICINE INC

NASDAQ:PRME (10/10/2025, 8:52:14 PM)

After market: 5.7 +0.02 (+0.35%)

5.68

-0.55 (-8.83%)



Find more stocks in the Stock Screener

Follow ChartMill for more